Premium
Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia?
Author(s) -
Nagrani Rani,
BowenSimpkins Peter,
Barrington Julian W.
Publication year - 2002
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2002.01274.x
Subject(s) - levonorgestrel , medicine , intrauterine device , health services , obstetrics , family planning , gynecology , surgery , population , research methodology , environmental health
Menorrhagia is a common gynaecological condition for which medical treatment is often ineffective and a large number of women undergo major surgery. Previous short term studies have shown a significant number of women with menstrual problems may avoid surgery if a levonorgestrel intrauterine system (LNG‐IUS) is fitted but no long term studies exist to ascertain if this benefit is sustained. This four to five year long term follow up study showed 50% of women continued to use the device and 67.4% avoided surgery. The LNG‐IUS is well accepted and effective in the management of menorrhagia and has major cost implications to the National Health Service.